Programmed Cell Death Ligand 1 Is Enriched in Mammary Stem Cells and Promotes Mammary Development and Regeneration
Programmed cell death ligand 1 (PD-L1) is widely expressed in a variety of human tumors, and inhibition of the PD-L1/PD-1 pathway represents one of the most promising therapy for many types of cancer. However, the physiological function of PD-L1 in tissue development is still unclear, although PD-L1...
Saved in:
Main Authors: | Ruirui Wang, Fujing Huang, Wei Wei, Yu Zhou, Zi Ye, Liya Yu, Junyuan Hu, Cheguo Cai |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5711ff2a33b74d539d154bba5351f0c2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Journal of mammary gland biology and neoplasia
Published: (1996) -
Epidemiological study of canine mammary tumors: age, breed, size and malignancy
by: Pastor,Nieves, et al.
Published: (2018) -
Evaluation of clinical and pathological characteristics of 155 canines with mammary tumours: a retrospective study
by: Sontas,BH, et al.
Published: (2009) -
Label-free isolation and cultivation of patient-matched human mammary epithelial and stromal cells from normal breast tissue
by: Maria K. Koch, et al.
Published: (2021) -
Morphometric and Hormonal Study of the Effect of Utrica diocia Extract on Mammary Glands in Rats
by: Jalili,C, et al.
Published: (2015)